By a GenomeWeb staff reporter
NEW YORK (GenomeWeb News) – Paul Berg will retire from his post on Affymetrix's board of directors in May, the company said this week. Berg has served on the company's board since 1993.
Registering provides access to this and other free content.
Already have an account?Login Now.
A company says it can generate likenesses of people based on their genetic profiles.
IBM's Watson is learning how to treat leukemia as a fellow at the MD Anderson Cancer Center, according to the Washington Post.
In Cell this week: dynamics of protein profusion and localization, melanoma classification schemes, and more.
In PNAS this week: ancestry and admixture in Brazilians, characterization of novel double-stranded RNA mycovirus, and more.